Long non-coding RNA MEG3 inhibits neovascularization in diabetic retinopathy by regulating microRNA miR-6720-5p and cytochrome B5 reductase 2

References

• Fenwick EK, Pesudovs K, Rees G, et al. The impact of diabetic retinopathy: understanding the patient’s perspective. Br J Ophthalmol. 2011;95(6):774–782.
   PubMed Web of Science ®Google Scholar
• Wong TY, Cheung CM, Larsen M, et al. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012.
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564.
   PubMed Web of Science ®Google Scholar
• Maniadakis N, Konstantakopoulou E. Cost effectiveness of treatments for diabetic retinopathy: a systematic literature review. PharmacoEconomics. 2019;37(8):995–1010.
   PubMed Web of Science ®Google Scholar
• Zimmer-Galler IE, Kimura AE, Gupta S. Diabetic retinopathy screening and the use of telemedicine. Curr Opin Ophthalmol. 2015;26(3):167–172.
   PubMed Web of Science ®Google Scholar
• Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354–361.
   PubMed Web of Science ®Google Scholar
• Jaé N, Dimmeler S. Long noncoding RNAs in diabetic retinopathy. Circ Res. 2015;116(7):1104–1106.
   PubMed Web of Science ®Google Scholar
• Biswas S, Sarabusky M, Chakrabarti S. Diabetic retinopathy, lncRNAs, and inflammation: a dynamic, interconnected network. J Clin Med. 2019;8(7):1033.
   Web of Science ®Google Scholar
• Thomas AA, Biswas S, Feng B, et al. lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia. 2019;62(3):517–530.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zou X, Li Y, et al. Downregulation of lncRNA BANCR participates in the development of retinopathy among diabetic patients. Exp Ther Med. 2019;17(5):4132–4138.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen X, Tong XL. Effect of lncRNA MEG3 on retinopathy in diabetic rats through regulating Fox01 expression. Eur Rev Med Pharmacol Sci. 2019;23(21):9163–9170.
   PubMed Web of Science ®Google Scholar
• Zhang D, Qin H, Leng Y, et al. LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-β1 and VEGF. Exp Ther Med. 2018;16(3):2337–2342.
   PubMed Web of Science ®Google Scholar
• Guo H, Ingolia NT, Weissman JS, et al. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466(7308):835–840.
   PubMed Web of Science ®Google Scholar
• Hao SC, Ma H, Niu ZF, et al. hUC-MSCs secreted exosomes inhibit the glioma cell progression through PTENP1/miR-10a-5p/PTEN pathway. Eur Rev Med Pharmacol Sci. 2019;23(22):10013–10023.
   PubMed Web of Science ®Google Scholar
• Yi W, Liu J, Qu S, et al. An 8 miRNA-based risk score system for predicting the prognosis of patients with papillary thyroid cancer. Technol Cancer Res Treat. 2020;19:1533033820965594.
   Web of Science ®Google Scholar
• Elahian F, Sepehrizadeh Z, Moghimi B, et al. Human cytochrome b5 reductase: structure, function, and potential applications. Crit Rev Biotechnol. 2014;34(2):134–143.
   PubMed Web of Science ®Google Scholar
• Ming H, Lan Y, He F, et al. Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis. Chin J Cancer. 2015;34(10):459–467.
   PubMedGoogle Scholar
• You J, Qi S, Du Y, et al. Multiple bioinformatics analyses of integrated gene expression profiling data and verification of hub genes associated with diabetic retinopathy. Med Sci Monit. 2020;26:e923146.
   PubMed Web of Science ®Google Scholar
• Gong Q, Xie J, Liu Y, et al. Differentially expressed microRNAs in the development of early diabetic retinopathy. J Diabetes Res. 2017;2017:4727942.
   PubMed Web of Science ®Google Scholar
• Song Y, Wu L, Li M, et al. Down-regulation of microRNA-592 in obesity contributes to hyperglycemia and insulin resistance. EBioMedicine. 2019;42:494–503.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhang H, Xu J. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma. Bioengineered. 2021;12(1):3993–4003.
   PubMed Web of Science ®Google Scholar
• Long H, Li Q, Xiao Z, et al. LncRNA MIR22HG promotes osteoarthritis progression via regulating miR-9-3p/ADAMTS5 pathway. Bioengineered. 2021;12(1):3148–3158.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhu Q, Lu L, et al. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Bioengineered. 2020;11(1):91–102.
   PubMed Web of Science ®Google Scholar
• Zou J, Liu KC, Wang WP, et al. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy. Life Sci. 2020;256:117888.
   PubMed Web of Science ®Google Scholar
• Tang D, Geng L, Ma J. lncRNA PROX1-AS1 mediates the migration and invasion of placental trophoblast cells via the miR-211-5p/caspase-9 axis. Bioengineered. 2021;12(1):4100–4110.
   PubMed Web of Science ®Google Scholar
• Govindarajan G, Mathews S, Srinivasan K, et al. Establishment of human retinal mitoscriptome gene expression signature for diabetic retinopathy using cadaver eyes. Mitochondrion. 2017;36:150–181.
   PubMed Web of Science ®Google Scholar
• He Y, Dan Y, Gao X, et al. DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K/Akt/mTOR signaling pathway. Am J Physiol Endocrinol Metab. 2021;320(3):E598–e608.
   PubMed Web of Science ®Google Scholar
• Tu Y, Zhu M, Wang Z, et al. Melatonin inhibits Müller cell activation and pro-inflammatory cytokine production via upregulating the MEG3/miR-204/Sirt1 axis in experimental diabetic retinopathy. J Cell Physiol. 2020;235(11):8724–8735.
   PubMed Web of Science ®Google Scholar
• Sabanayagam C, Banu R, Chee ML, et al. Incidence and progression of diabetic retinopathy: a systematic review. Lancet Diabetes Endocrinol. 2019;7(2):140–149.
   PubMed Web of Science ®Google Scholar
• Satari M, Aghadavod E, Mirhosseini N, et al. The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy. J Cell Biochem. 2019;120(6):9514–9521.
   PubMed Web of Science ®Google Scholar
• Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018;19(6)1816.
   Web of Science ®Google Scholar
• Sulaiman RS, Merrigan S, Quigley J, et al. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy. Sci Rep. 2016;6:25509.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Taheri M. Maternally expressed gene 3 (MEG3): a tumor suppressor long non coding RNA. Biomed Pharmacothe. 2019;118:109129.
   PubMed Web of Science ®Google Scholar
• Qiu GZ, Tian W, Fu HT, et al. Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction. Biochem Biophys Res Commun. 2016;471(1):135–141.
   PubMed Web of Science ®Google Scholar
• Xiao F, Li L, Fu JS, et al. Regulation of the miR-19b-mediated SOCS6-JAK2/STAT3 pathway by lncRNA MEG3 is involved in high glucose-induced apoptosis in hRMECs. Biosci Rep. 2020;40(7). DOI:10.1042/BSR20194370
   Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353–358.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Sun W, Guo Z, et al. Mechanisms of lncRNA/microRNA interactions in angiogenesis. Life Sci. 2020;254:116900.
   PubMed Web of Science ®Google Scholar
• Wan J, Liu B. Construction of lncRNA-related ceRNA regulatory network in diabetic subdermal endothelial cells. Bioengineered. 2021;12(1):2592–2602.
   PubMed Web of Science ®Google Scholar
• Tong P, Peng QH, Gu LM, et al. LncRNA-MEG3 alleviates high glucose induced inflammation and apoptosis of retina epithelial cells via regulating miR-34a/SIRT1 axis. Exp Mol Pathol. 2019;107:102–109.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286.
   PubMedGoogle Scholar
• Spranger J, Pfeiffer AF. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S438–450.
   PubMedGoogle Scholar
• Bolinger MT, Antonetti DA. Moving past anti-VEGF: novel therapies for treating diabetic retinopathy. Int J Mol Sci. 2016;17(9):1498.
   PubMed Web of Science ®Google Scholar